Metabolic syndrome: Evaluation of pathological and therapeutic outcomes

Phillippa J. Miranda; Ralph A. DeFronzo; Robert M. Califf; John R. Guyton

doi:10.1016/j.ahj.2004.07.012

Metabolic syndrome: Evaluation of pathological and therapeutic outcomes

Phillippa J. Miranda
, Ralph A. DeFronzo
, Robert M. Califf
, John R. Guyton

Division of Diabetes

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Abstract

Despite its etiologic complexities, regulatory hurdles, and clinical uncertainties, metabolic syndrome must be recognized as a looming danger to public health in the United States. It demands the best efforts of clinicians, bench scientists, regulators, advocates, and clinical trialists to find viable solutions in the near future.

Original language	English (US)
Pages (from-to)	20-32
Number of pages	13
Journal	American Heart Journal
Volume	149
Issue number	1
DOIs	https://doi.org/10.1016/j.ahj.2004.07.012
State	Published - Jan 2005

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ahj.2004.07.012

Cite this

@article{add6683b3eb14a548e11f4a8b6570cac,

title = "Metabolic syndrome: Evaluation of pathological and therapeutic outcomes",

abstract = "Despite its etiologic complexities, regulatory hurdles, and clinical uncertainties, metabolic syndrome must be recognized as a looming danger to public health in the United States. It demands the best efforts of clinicians, bench scientists, regulators, advocates, and clinical trialists to find viable solutions in the near future.",

author = "Miranda, \{Phillippa J.\} and DeFronzo, \{Ralph A.\} and Califf, \{Robert M.\} and Guyton, \{John R.\}",

year = "2005",

month = jan,

doi = "10.1016/j.ahj.2004.07.012",

language = "English (US)",

volume = "149",

pages = "20--32",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Metabolic syndrome

T2 - Evaluation of pathological and therapeutic outcomes

AU - Miranda, Phillippa J.

AU - DeFronzo, Ralph A.

AU - Califf, Robert M.

AU - Guyton, John R.

PY - 2005/1

Y1 - 2005/1

N2 - Despite its etiologic complexities, regulatory hurdles, and clinical uncertainties, metabolic syndrome must be recognized as a looming danger to public health in the United States. It demands the best efforts of clinicians, bench scientists, regulators, advocates, and clinical trialists to find viable solutions in the near future.

AB - Despite its etiologic complexities, regulatory hurdles, and clinical uncertainties, metabolic syndrome must be recognized as a looming danger to public health in the United States. It demands the best efforts of clinicians, bench scientists, regulators, advocates, and clinical trialists to find viable solutions in the near future.

UR - https://www.scopus.com/pages/publications/12344327474

UR - https://www.scopus.com/pages/publications/12344327474#tab=citedBy

U2 - 10.1016/j.ahj.2004.07.012

DO - 10.1016/j.ahj.2004.07.012

M3 - Article

C2 - 15660031

AN - SCOPUS:12344327474

SN - 0002-8703

VL - 149

SP - 20

EP - 32

JO - American Heart Journal

JF - American Heart Journal

IS - 1

ER -

Metabolic syndrome: Evaluation of pathological and therapeutic outcomes

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this